Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon F Keele

Showing results (151-160 of 230) with videos related to

Pageof 23
Sort By:
The Journal of Infectious Diseases|October 4, 2019
Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus StrainsAndrew D Redd, Nicole A Doria-Rose, Joshua A Weiner, et al.
Journal of Theoretical Biology|August 8, 2009
Modeling sequence evolution in acute HIV-1 infectionHa Youn Lee, Elena E Giorgi, Brandon F Keele, et al.
Plos One|May 17, 2011
Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapyCynthia Gay, Oliver Dibben, Jeffrey A Anderson, et al.
International Journal of Cancer|May 24, 2022
Systematic analysis of Kaposi's sarcoma (KS)-associated herpesvirus genomes from a KS case-control study in Cameroon: Evidence of dual infections but no association between viral sequence variation and KS riskVickie A Marshall, Nicholas C Fisher, Charles A Goodman, et al.
Plos Pathogens|July 15, 2024
Sequencing of Kaposi's Sarcoma Herpesvirus (KSHV) genomes from persons of diverse ethnicities and provenances with KSHV-associated diseases demonstrate multiple infections, novel polymorphisms, and low intra-host varianceVickie A Marshall, Elena M Cornejo Castro, Charles A Goodman, et al.
Journal of Virology|January 18, 2013
Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposureMonica Vaccari, Brandon F Keele, Steven E Bosinger, et al.
The Journal of Clinical Investigation|October 5, 2020
HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virusElias K Halvas, Kevin W Joseph, Leah D Brandt, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Elevated Plasma Viral Loads in Romidepsin-Treated Simian Immunodeficiency Virus-Infected Rhesus Macaques on Suppressive Combination Antiretroviral TherapyGregory Q Del Prete, Kelli Oswald, Abigail Lara, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
Distinct phases of immune system programming during ART-suppressed immunodeficiency virus infectionMaanasa Kaza, Benjamin Varco-Merth, G W McElfresh, et al.
Plos Pathogens|October 2, 2010
Impact of simian immunodeficiency virus infection on chimpanzee population dynamicsRebecca S Rudicell, James Holland Jones, Emily E Wroblewski, et al.
Pageof 23

Showing results (151-160 of 230) with videos related to

Sort By:
Pageof 23
The Journal of Infectious Diseases|October 4, 2019
Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus StrainsAndrew D Redd, Nicole A Doria-Rose, Joshua A Weiner, et al.
Journal of Theoretical Biology|August 8, 2009
Modeling sequence evolution in acute HIV-1 infectionHa Youn Lee, Elena E Giorgi, Brandon F Keele, et al.
Plos One|May 17, 2011
Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapyCynthia Gay, Oliver Dibben, Jeffrey A Anderson, et al.
International Journal of Cancer|May 24, 2022
Systematic analysis of Kaposi's sarcoma (KS)-associated herpesvirus genomes from a KS case-control study in Cameroon: Evidence of dual infections but no association between viral sequence variation and KS riskVickie A Marshall, Nicholas C Fisher, Charles A Goodman, et al.
Plos Pathogens|July 15, 2024
Sequencing of Kaposi's Sarcoma Herpesvirus (KSHV) genomes from persons of diverse ethnicities and provenances with KSHV-associated diseases demonstrate multiple infections, novel polymorphisms, and low intra-host varianceVickie A Marshall, Elena M Cornejo Castro, Charles A Goodman, et al.
Journal of Virology|January 18, 2013
Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposureMonica Vaccari, Brandon F Keele, Steven E Bosinger, et al.
The Journal of Clinical Investigation|October 5, 2020
HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virusElias K Halvas, Kevin W Joseph, Leah D Brandt, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Elevated Plasma Viral Loads in Romidepsin-Treated Simian Immunodeficiency Virus-Infected Rhesus Macaques on Suppressive Combination Antiretroviral TherapyGregory Q Del Prete, Kelli Oswald, Abigail Lara, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
Distinct phases of immune system programming during ART-suppressed immunodeficiency virus infectionMaanasa Kaza, Benjamin Varco-Merth, G W McElfresh, et al.
Plos Pathogens|October 2, 2010
Impact of simian immunodeficiency virus infection on chimpanzee population dynamicsRebecca S Rudicell, James Holland Jones, Emily E Wroblewski, et al.
Pageof 23